Menarini

Menarini is an Italian pharmaceutical company, founded in 1926 by the Menarini family. It is headquartered in Florence, Italy, and operates in over 100 countries. The company is known for its focus on research and development, with a strong emphasis on innovation and quality. Menarini's product portfolio includes a wide range of therapeutic areas, such as oncology, neurology, gastroenterology, and cardiovascular diseases. Some of its notable products are the antiplatelet drug Ticagrelor, the antiepileptic drug Levetiracetam, and the antiemetic drug Ondansetron. Menarini is also involved in the development of biosimilars and has a significant presence in the biopharmaceutical market. The company is listed on the Milan Stock Exchange and is part of the FTSE MIB index. Menarini's commitment to sustainability and corporate social responsibility is reflected in its initiatives, such as the Menarini Foundation, which supports various health-related projects worldwide.